Adrenal vein sampling with and without cosyntropin stimulation for detection of surgically remediable aldosteronism
Open Access
- 7 March 2019
- journal article
- research article
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 2 (2) , e00066
Abstract
Summary: Context and Objective: Bilateral adrenal vein sampling (AVS), the diagnostic standard for identifying surgically remediable aldosteronism (SRA), is commonly performed after cosyntropin stimulation (post‐ACTHstim). The role of AVS without cosyntropin stimulation (pre‐ACTHstim) has not been established. The selectivity index (SI), the adrenal vein (av) serum cortisol concentration divided by that in a peripheral vein, confirms av sampling. The minimally acceptable SI is controversial. The objectives of this study were to determine the role of pre‐ACTHstim AVS and a predetermined SI.Design: Using biochemical cure as the endpoint, we performed a retrospective head‐to‐head comparison of pre‐ACTHstim AVS to post‐ACTHstim AVS. The specificity of a predetermined minimum SI of 1.5 in pre‐ACTHstim AVS was determined.Patients: At a regional AVS referral centre, we analysed 32 patients who had undergone simultaneous bilateral AVS both pre‐ and post‐ACTHstim and had returned for postadrenalectomy evaluation.Measurements: Simultaneous bilateral AVS was performed with measurements of venous concentrations of aldosterone and cortisol. End points were postadrenalectomy plasma renin activity, serum aldosterone concentration, and number of antihypertensive medications.Results: All 32 patients achieved a biochemical cure following adrenalectomy. The two AVS protocols were complementary. Notably, seven patients (22%; CI = 11‐38) were found to have SRA by a lateralization index (LI) > 4 on the pre‐ACTHstim AVS, but not on the post‐ACTHstim AVS. SI pre‐ACTHstim was divided into tertiles. Specificity was 100% in all.Conclusions: Simultaneous bilateral AVS performed both pre‐ACTHstim and post‐ACTHstim maximizes SRA identification. A SI of 1.5 pre‐ACTHstim does not reduce specificity.Keywords
This publication has 23 references indexed in Scilit:
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysisThe Lancet Diabetes & Endocrinology, 2018
- Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort studyThe Lancet Diabetes & Endocrinology, 2018
- Cardiovascular Complications Associated With Primary AldosteronismHypertension, 2013
- Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational studyThe Lancet, 2008
- Adrenal causes of hypertension: Pheochromocytoma and primary aldosteronismReviews in Endocrine and Metabolic Disorders, 2007
- Increased Arterial Wall Stiffness in Primary Aldosteronism in Comparison With Essential HypertensionAmerican Journal of Hypertension, 2006
- Renal Damage in Primary AldosteronismHypertension, 2006
- Low-renin status in therapy-resistant hypertensionJournal Of Hypertension, 2004
- Left Ventricular Hypertrophy Is More Prominent in Patients with Primary Aldosteronism than in Patients with Other Types of Secondary Hypertension.Hypertension Research, 1997
- Hyperaldosteronism: sampling the adrenal veins.Radiology, 1996